As CDC Head South Africa, you will lead the country clinical trial operations organisation and its adjacent-affiliate scope as part of Global Trial Portfolio (GTP). Reporting directly to the Vice President, Trial Operations in HQ, you will be accountable for translating the global portfolio and development strategy into strong local execution, building a resilient and scalable organisation, and ensuring that South African and adjacent-affiliate insights shape global decisions. Your leadership will accelerate trial delivery while safeguarding patient safety, quality and compliance, and strengthening the site and investigator partnerships that bring clinical research closer to people living with serious chronic diseases.
You are a proven clinical operations leader who can set direction, build teams and deliver trials to the highest quality.
You will lead the CDC as an integrated part of One GTP, with end-to-end accountability for the CDC’s contribution to portfolio planning, country readiness, trial execution, organisational capability, resource deployment, performance and inspection readiness across South Africa and adjacent affiliates.
You will be part of GTP Trial Operations and will lead the South Africa Clinical Development Centre and its adjacent-affiliate clinical operations scope. The role has a direct reporting line to the Vice President, Trial Operations in HQ and a close local partnership with the affiliate General Manager and the Medical & Regulatory (M&R) organisation.
Your closest partners will be the Vice President, Trial Operations, peer CDC Heads, GTP Clinical Operations and portfolio-planning colleagues, Clinical Medical Management, trial squads and Global Project Teams. Locally, you will partner closely with the affiliate General Manager, M&R, P&O, Finance, Market Access and relevant business teams, while preserving clear functional accountabilities. Externally, you will work with investigators, study nurses and coordinators, health authorities, ethics committees, vendors and industry partners.
Clear priorities, transparent performance dialogue and early escalation will keep these relationships moving at pace. You will operate as a One GTP leader, make decisions within your mandate without waiting for unnecessary alignment, and resolve tensions between global portfolio priorities and local realities. You will put enterprise and patient outcomes ahead of functional boundaries while maintaining strong collaboration with the local M&R organisation.
You will be trusted to lead and supported to perform at your best, with clear performance expectations and recognition for results. Your voice will shape decisions on how clinical operations evolve. You will grow alongside colleagues through the work itself and relevant learning offerings, and you will develop others in turn.
Your impact begins today. If you are ready to lead the South Africa CDC as part of One GTP and shape how the global trial portfolio is delivered locally, apply for the Associate Director, CDC Head South Africa role by November 5, 2026. Applications are reviewed on an ongoing basis, so we encourage you to apply as soon as possible.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.
Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html